Vikram Kapur shares that in 2022, APAC ex-China had its best year yet in terms of healthcare private equity deal count. In addition, he stated that for the longest time, Asia’s challenge was not having large enough businesses to deploy capital in, but there’s been more and more billion-dollar deals in the last few years.